High Content Screening Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: HA703C2D3E8BEN
Market Monitor Global

Abstracts

High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluorescence imaging, and other visualization processes to get quantitative data from cell populations.

This report contains market size and forecasts of High Content Screening in Global, including the following market information:

Global High Content Screening Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global High Content Screening market was valued at 579.9 million in 2021 and is projected to reach US$ 992.9 million by 2028, at a CAGR of 8.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Consumables Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of High Content Screening include Molecular Devices, Thermo Fisher Scientific, PerkinElmer Inc., Becton, GE Healthcare, Dickinson and Company, Merck KGaA, Cell Signaling Technology and Thorlabs, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the High Content Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global High Content Screening Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global High Content Screening Market Segment Percentages, by Type, 2021 (%)

• Consumables
• Microplates
• Instruments
• Software and Service

Global High Content Screening Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global High Content Screening Market Segment Percentages, by Application, 2021 (%)

• Primary & Secondary Screening
• Compound Profiling
• Target Identification & Validation

Global High Content Screening Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global High Content Screening Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies High Content Screening revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies High Content Screening revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Molecular Devices
• Thermo Fisher Scientific
• PerkinElmer Inc.
• Becton
• GE Healthcare
• Dickinson and Company
• Merck KGaA
• Cell Signaling Technology
• Thorlabs, Inc.
• Genedata AG
• Yokogawa Electric Corporation

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 High Content Screening Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global High Content Screening Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HIGH CONTENT SCREENING OVERALL MARKET SIZE

2.1 Global High Content Screening Market Size: 2021 VS 2028
2.2 Global High Content Screening Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top High Content Screening Players in Global Market
3.2 Top Global High Content Screening Companies Ranked by Revenue
3.3 Global High Content Screening Revenue by Companies
3.4 Top 3 and Top 5 High Content Screening Companies in Global Market, by Revenue in 2021
3.5 Global Companies High Content Screening Product Type
3.6 Tier 1, Tier 2 and Tier 3 High Content Screening Players in Global Market
  3.6.1 List of Global Tier 1 High Content Screening Companies
  3.6.2 List of Global Tier 2 and Tier 3 High Content Screening Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global High Content Screening Market Size Markets, 2021 & 2028
  4.1.2 Consumables
  4.1.3 Microplates
  4.1.4 Instruments
  4.1.5 Software and Service
4.2 By Type - Global High Content Screening Revenue & Forecasts
  4.2.1 By Type - Global High Content Screening Revenue, 2017-2022
  4.2.2 By Type - Global High Content Screening Revenue, 2023-2028
  4.2.3 By Type - Global High Content Screening Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global High Content Screening Market Size, 2021 & 2028
  5.1.2 Primary & Secondary Screening
  5.1.3 Compound Profiling
  5.1.4 Target Identification & Validation
5.2 By Application - Global High Content Screening Revenue & Forecasts
  5.2.1 By Application - Global High Content Screening Revenue, 2017-2022
  5.2.2 By Application - Global High Content Screening Revenue, 2023-2028
  5.2.3 By Application - Global High Content Screening Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global High Content Screening Market Size, 2021 & 2028
6.2 By Region - Global High Content Screening Revenue & Forecasts
  6.2.1 By Region - Global High Content Screening Revenue, 2017-2022
  6.2.2 By Region - Global High Content Screening Revenue, 2023-2028
  6.2.3 By Region - Global High Content Screening Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America High Content Screening Revenue, 2017-2028
  6.3.2 US High Content Screening Market Size, 2017-2028
  6.3.3 Canada High Content Screening Market Size, 2017-2028
  6.3.4 Mexico High Content Screening Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe High Content Screening Revenue, 2017-2028
  6.4.2 Germany High Content Screening Market Size, 2017-2028
  6.4.3 France High Content Screening Market Size, 2017-2028
  6.4.4 U.K. High Content Screening Market Size, 2017-2028
  6.4.5 Italy High Content Screening Market Size, 2017-2028
  6.4.6 Russia High Content Screening Market Size, 2017-2028
  6.4.7 Nordic Countries High Content Screening Market Size, 2017-2028
  6.4.8 Benelux High Content Screening Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia High Content Screening Revenue, 2017-2028
  6.5.2 China High Content Screening Market Size, 2017-2028
  6.5.3 Japan High Content Screening Market Size, 2017-2028
  6.5.4 South Korea High Content Screening Market Size, 2017-2028
  6.5.5 Southeast Asia High Content Screening Market Size, 2017-2028
  6.5.6 India High Content Screening Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America High Content Screening Revenue, 2017-2028
  6.6.2 Brazil High Content Screening Market Size, 2017-2028
  6.6.3 Argentina High Content Screening Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa High Content Screening Revenue, 2017-2028
  6.7.2 Turkey High Content Screening Market Size, 2017-2028
  6.7.3 Israel High Content Screening Market Size, 2017-2028
  6.7.4 Saudi Arabia High Content Screening Market Size, 2017-2028
  6.7.5 UAE High Content Screening Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Molecular Devices
  7.1.1 Molecular Devices Corporate Summary
  7.1.2 Molecular Devices Business Overview
  7.1.3 Molecular Devices High Content Screening Major Product Offerings
  7.1.4 Molecular Devices High Content Screening Revenue in Global Market (2017-2022)
  7.1.5 Molecular Devices Key News
7.2 Thermo Fisher Scientific
  7.2.1 Thermo Fisher Scientific Corporate Summary
  7.2.2 Thermo Fisher Scientific Business Overview
  7.2.3 Thermo Fisher Scientific High Content Screening Major Product Offerings
  7.2.4 Thermo Fisher Scientific High Content Screening Revenue in Global Market (2017-2022)
  7.2.5 Thermo Fisher Scientific Key News
7.3 PerkinElmer Inc.
  7.3.1 PerkinElmer Inc. Corporate Summary
  7.3.2 PerkinElmer Inc. Business Overview
  7.3.3 PerkinElmer Inc. High Content Screening Major Product Offerings
  7.3.4 PerkinElmer Inc. High Content Screening Revenue in Global Market (2017-2022)
  7.3.5 PerkinElmer Inc. Key News
7.4 Becton
  7.4.1 Becton Corporate Summary
  7.4.2 Becton Business Overview
  7.4.3 Becton High Content Screening Major Product Offerings
  7.4.4 Becton High Content Screening Revenue in Global Market (2017-2022)
  7.4.5 Becton Key News
7.5 GE Healthcare
  7.5.1 GE Healthcare Corporate Summary
  7.5.2 GE Healthcare Business Overview
  7.5.3 GE Healthcare High Content Screening Major Product Offerings
  7.5.4 GE Healthcare High Content Screening Revenue in Global Market (2017-2022)
  7.5.5 GE Healthcare Key News
7.6 Dickinson and Company
  7.6.1 Dickinson and Company Corporate Summary
  7.6.2 Dickinson and Company Business Overview
  7.6.3 Dickinson and Company High Content Screening Major Product Offerings
  7.6.4 Dickinson and Company High Content Screening Revenue in Global Market (2017-2022)
  7.6.5 Dickinson and Company Key News
7.7 Merck KGaA
  7.7.1 Merck KGaA Corporate Summary
  7.7.2 Merck KGaA Business Overview
  7.7.3 Merck KGaA High Content Screening Major Product Offerings
  7.7.4 Merck KGaA High Content Screening Revenue in Global Market (2017-2022)
  7.7.5 Merck KGaA Key News
7.8 Cell Signaling Technology
  7.8.1 Cell Signaling Technology Corporate Summary
  7.8.2 Cell Signaling Technology Business Overview
  7.8.3 Cell Signaling Technology High Content Screening Major Product Offerings
  7.8.4 Cell Signaling Technology High Content Screening Revenue in Global Market (2017-2022)
  7.8.5 Cell Signaling Technology Key News
7.9 Thorlabs, Inc.
  7.9.1 Thorlabs, Inc. Corporate Summary
  7.9.2 Thorlabs, Inc. Business Overview
  7.9.3 Thorlabs, Inc. High Content Screening Major Product Offerings
  7.9.4 Thorlabs, Inc. High Content Screening Revenue in Global Market (2017-2022)
  7.9.5 Thorlabs, Inc. Key News
7.10 Genedata AG
  7.10.1 Genedata AG Corporate Summary
  7.10.2 Genedata AG Business Overview
  7.10.3 Genedata AG High Content Screening Major Product Offerings
  7.10.4 Genedata AG High Content Screening Revenue in Global Market (2017-2022)
  7.10.5 Genedata AG Key News
7.11 Yokogawa Electric Corporation
  7.11.1 Yokogawa Electric Corporation Corporate Summary
  7.11.2 Yokogawa Electric Corporation Business Overview
  7.11.3 Yokogawa Electric Corporation High Content Screening Major Product Offerings
  7.11.4 Yokogawa Electric Corporation High Content Screening Revenue in Global Market (2017-2022)
  7.11.5 Yokogawa Electric Corporation Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. High Content Screening Market Opportunities & Trends in Global Market
Table 2. High Content Screening Market Drivers in Global Market
Table 3. High Content Screening Market Restraints in Global Market
Table 4. Key Players of High Content Screening in Global Market
Table 5. Top High Content Screening Players in Global Market, Ranking by Revenue (2021)
Table 6. Global High Content Screening Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global High Content Screening Revenue Share by Companies, 2017-2022
Table 8. Global Companies High Content Screening Product Type
Table 9. List of Global Tier 1 High Content Screening Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 High Content Screening Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global High Content Screening Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - High Content Screening Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - High Content Screening Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global High Content Screening Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - High Content Screening Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - High Content Screening Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global High Content Screening Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global High Content Screening Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global High Content Screening Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America High Content Screening Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America High Content Screening Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe High Content Screening Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe High Content Screening Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia High Content Screening Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia High Content Screening Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America High Content Screening Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America High Content Screening Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa High Content Screening Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa High Content Screening Revenue, (US$, Mn), 2023-2028
Table 30. Molecular Devices Corporate Summary
Table 31. Molecular Devices High Content Screening Product Offerings
Table 32. Molecular Devices High Content Screening Revenue (US$, Mn), (2017-2022)
Table 33. Thermo Fisher Scientific Corporate Summary
Table 34. Thermo Fisher Scientific High Content Screening Product Offerings
Table 35. Thermo Fisher Scientific High Content Screening Revenue (US$, Mn), (2017-2022)
Table 36. PerkinElmer Inc. Corporate Summary
Table 37. PerkinElmer Inc. High Content Screening Product Offerings
Table 38. PerkinElmer Inc. High Content Screening Revenue (US$, Mn), (2017-2022)
Table 39. Becton Corporate Summary
Table 40. Becton High Content Screening Product Offerings
Table 41. Becton High Content Screening Revenue (US$, Mn), (2017-2022)
Table 42. GE Healthcare Corporate Summary
Table 43. GE Healthcare High Content Screening Product Offerings
Table 44. GE Healthcare High Content Screening Revenue (US$, Mn), (2017-2022)
Table 45. Dickinson and Company Corporate Summary
Table 46. Dickinson and Company High Content Screening Product Offerings
Table 47. Dickinson and Company High Content Screening Revenue (US$, Mn), (2017-2022)
Table 48. Merck KGaA Corporate Summary
Table 49. Merck KGaA High Content Screening Product Offerings
Table 50. Merck KGaA High Content Screening Revenue (US$, Mn), (2017-2022)
Table 51. Cell Signaling Technology Corporate Summary
Table 52. Cell Signaling Technology High Content Screening Product Offerings
Table 53. Cell Signaling Technology High Content Screening Revenue (US$, Mn), (2017-2022)
Table 54. Thorlabs, Inc. Corporate Summary
Table 55. Thorlabs, Inc. High Content Screening Product Offerings
Table 56. Thorlabs, Inc. High Content Screening Revenue (US$, Mn), (2017-2022)
Table 57. Genedata AG Corporate Summary
Table 58. Genedata AG High Content Screening Product Offerings
Table 59. Genedata AG High Content Screening Revenue (US$, Mn), (2017-2022)
Table 60. Yokogawa Electric Corporation Corporate Summary
Table 61. Yokogawa Electric Corporation High Content Screening Product Offerings
Table 62. Yokogawa Electric Corporation High Content Screening Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. High Content Screening Segment by Type in 2021
Figure 2. High Content Screening Segment by Application in 2021
Figure 3. Global High Content Screening Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global High Content Screening Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global High Content Screening Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by High Content Screening Revenue in 2021
Figure 8. By Type - Global High Content Screening Revenue Market Share, 2017-2028
Figure 9. By Application - Global High Content Screening Revenue Market Share, 2017-2028
Figure 10. By Region - Global High Content Screening Revenue Market Share, 2017-2028
Figure 11. By Country - North America High Content Screening Revenue Market Share, 2017-2028
Figure 12. US High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 13. Canada High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe High Content Screening Revenue Market Share, 2017-2028
Figure 16. Germany High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 17. France High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 19. Italy High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 20. Russia High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia High Content Screening Revenue Market Share, 2017-2028
Figure 24. China High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 25. Japan High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 28. India High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America High Content Screening Revenue Market Share, 2017-2028
Figure 30. Brazil High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa High Content Screening Revenue Market Share, 2017-2028
Figure 33. Turkey High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 34. Israel High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 36. UAE High Content Screening Revenue, (US$, Mn), 2017-2028
Figure 37. Molecular Devices High Content Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Thermo Fisher Scientific High Content Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. PerkinElmer Inc. High Content Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Becton High Content Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GE Healthcare High Content Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Dickinson and Company High Content Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck KGaA High Content Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cell Signaling Technology High Content Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Thorlabs, Inc. High Content Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Genedata AG High Content Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Yokogawa Electric Corporation High Content Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)